Lumativa Raises First Round

Lumativa AG, a Swiss developer of anti-infectives for women's health, has raised CHF 18 million ($16.24m) in Series A funding. Backers include Atlas Venture, BB Biotech Ventures and BioMedInvest. www.lumativa.com